@DeepValueBagger@StockMKTNewz You wish
Just like it was RIP HIMS when Amazon opened pharmacy
ASTS is so far ahead in the connectivity game that even SpaceX can’t fuck with them
You will watch ASTS 10x minimum over the next 5-10 years
@jorgedenas@Sandeman52@TheLongInvest Long invest has great track record inside the group
Bought HIMS in 20s, trimmed at $62 and rebought at $14. ASTS in 20s and trimmed at $117. SLV in 20s and sold half at $90
Etc etc.
Ppl just love to hate online and expect overnight results. Guy has plenty of great entries
@jonesrrrrrr@Mr_Derivatives Yeah I mean I wouldn’t say it’s that difficult to run up a GLP company rn
With HIMS you’re investing in the long term vision of the platform and D2C healthcare overall
@jonesrrrrrr@Mr_Derivatives “Just a boner pill company” “just a GLP company” lazy take
Founder led, customer first platform with multiple verticals aside from peptides including bloodwork panels, cancer screening, metabolic & hormone testing
Chance to disrupt healthcare the way Amazon disrupted retail